1. A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours. (November 2016) Authors: Jamieson, David; Griffin, Melanie J.; Sludden, Julieann; Drew, Yvette; Cresti, Nicola; Swales, Karen; Merriman, Mark; Allen, Rodger; Bevan, Paul; Buerkle, Markus; Mala, Carola; Coyle, Vicky; Rodgers, Lisa; Dean, Emma; Greystoke, Alastair; Banerji, Udai; Wilson, Richard H.; Evans, T.R. Jeffery; An... Journal: European journal of cancer Issue: Volume 68(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in NSCLC. (April 2023) Authors: Horne, Ashley; Brown, Sarah; Coyle, Vicky; Franks, Kevin; Hassani, Adam; Harrow, Stephen; Hatton, Matthew; Hiley, Crispin; Kendall, Jessica; Oughton, Jamie; Shaw, Paul; Walker, Fiona; Yang, Huiqi; Chalmers, Anthony; Faivre-Finn, Corinne; Greystoke, Alastair Journal: Lung cancer Issue: Volume 178(2023)Supplement 1 Page Start: S86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer. (20th April 2021) Authors: Alderdice, Matthew; Craig, Stephanie G; Humphries, Matthew P; Gilmore, Alan; Johnston, Nicole; Bingham, Victoria; Coyle, Vicky; Senevirathne, Seedevi; Longley, Daniel B; Loughrey, Maurice B; McQuaid, Stephen; James, Jacqueline A; Salto-Tellez, Manuel; Lawler, Mark; McArt, Darragh&n... Journal: NAR genomics and bioinformatics Issue: Volume 3:issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗